{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:06:21Z","timestamp":1749701181787,"version":"3.41.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,10]]},"DOI":"10.7759\/cureus.85740","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:39:13Z","timestamp":1749620353000},"source":"Crossref","is-referenced-by-count":0,"title":["Heavy Chain Deposition Disease in Monoclonal Gammopathy of Renal Significance: A Prodrome of Multiple Myeloma Case and Literature Review"],"prefix":"10.7759","author":[{"given":"Sahana","family":"Gnanasampanthan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios P","family":"Samelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice","family":"Roufosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kousios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung N","year":"2012","unstructured":"Leung N, Bridoux F, Hutchison CA, et al.. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012, 120:4292-5. 10.1182\/blood-2012-07-445304","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution","volume":"7","author":"Nasr SH","year":"2012","unstructured":"Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, D'Agati VD, Leung N. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol. 2012, 7:231-9. 10.2215\/CJN.08640811","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: the disease spectrum","volume":"12","author":"Lin J","year":"2001","unstructured":"Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D'Agati VD. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001, 12:1482-92. 10.1681\/ASN.V1271482","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.08.013","article-title":"Heavy chain deposition disease: clinicopathologic characteristics of a Chinese case series","volume":"75","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Li X, Liang D, et al.. Heavy chain deposition disease: clinicopathologic characteristics of a Chinese case series. Am J Kidney Dis. 2020, 75:736-43. 10.1053\/j.ajkd.2019.08.013","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24528","article-title":"Outcomes of patients with renal monoclonal immunoglobulin deposition disease","volume":"91","author":"Kourelis TV","year":"2016","unstructured":"Kourelis TV, Nasr SH, Dispenzieri A, et al.. Outcomes of patients with renal monoclonal immunoglobulin deposition disease. Am J Hematol. 2016, 91:1123-8. 10.1002\/ajh.24528","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1267349","article-title":"Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens","volume":"58","author":"Ziogas DC","year":"2017","unstructured":"Ziogas DC, Kastritis E, Terpos E, et al.. Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens. Leuk Lymphoma. 2017, 58:1832-9. 10.1080\/10428194.2016.1267349","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21129","article-title":"Complement 3 is involved in changing the phenotype of human glomerular mesangial cells","volume":"213","author":"Wan JX","year":"2007","unstructured":"Wan JX, Fukuda N, Endo M, et al.. Complement 3 is involved in changing the phenotype of human glomerular mesangial cells. J Cell Physiol. 2007, 213:495-501. 10.1002\/jcp.21129","journal-title":"J Cell Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly F","year":"2019","unstructured":"Joly F, Cohen C, Javaugue V, et al.. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study. Blood. 2019, 133:576-87. 10.1182\/blood-2018-09-872028","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.201","article-title":"Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease","volume":"88","author":"Cohen C","year":"2015","unstructured":"Cohen C, Royer B, Javaugue V, et al.. Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease. Kidney Int. 2015, 88:1135-43. 10.1038\/ki.2015.201","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfs062","article-title":"Heavy-chain deposition disease: a morphological, immunofluorescence and ultrastructural assessment","volume":"5","author":"Rane S","year":"2012","unstructured":"Rane S, Rana S, Mudrabettu C, Jha V, Joshi K. Heavy-chain deposition disease: a morphological, immunofluorescence and ultrastructural assessment. Clin Kidney J. 2012, 5:383-9. 10.1093\/ckj\/sfs062","journal-title":"Clin Kidney J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-658872","article-title":"Natural history and outcome of light chain deposition disease","volume":"126","author":"Sayed RH","year":"2015","unstructured":"Sayed RH, Wechalekar AD, Gilbertson JA, et al.. Natural history and outcome of light chain deposition disease. Blood. 2015, 126:2805-10. 10.1182\/blood-2015-07-658872","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.08.040","article-title":"Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors","volume":"42","author":"Pozzi C","year":"2003","unstructured":"Pozzi C, D'Amico M, Fogazzi GB, et al.. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis. 2003, 42:1154-63. 10.1053\/j.ajkd.2003.08.040","journal-title":"Am J Kidney Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363237-heavy-chain-deposition-disease-in-monoclonal-gammopathy-of-renal-significance-a-prodrome-of-multiple-myeloma-case-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:39:13Z","timestamp":1749620353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363237-heavy-chain-deposition-disease-in-monoclonal-gammopathy-of-renal-significance-a-prodrome-of-multiple-myeloma-case-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.85740","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}